PREDICTIVE FACTORS OF SURVIVAL AFTER NEOADJUVANT RADIOTHERAPY AND CHEMOTHERAPY IN HIGH-RISK BREAST CANCER

被引：0
|
作者：
Matuschek, Christiane [1 ]
Budach, Wilfried [1 ]
Tamaskovics, Balint [1 ]
Fischer, Johannes [1 ]
Boelke, Edwin [1 ]
Corradini, Stefanie [2 ]
Kammers, Kai [3 ]
Kraemling, Carolin Nestle [1 ]
Fehm, Tanja [1 ]
Wollandt, Sylvia [1 ]
Speer, Vanessa [1 ]
Haussmann, Jan [1 ]
机构：
[1] Heinrich Heine Univ, Dusseldorf, Germany
[2] Univ Hosp LMU, Munich, Germany
[3] Johns Hopkins Univ, Baltimore, MD USA
来源：
RADIOTHERAPY AND ONCOLOGY | 2021年 / 163卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
86
引用
收藏
页码：S38 / S39
页数：2
相关论文
共 50 条
  • [1] Predictive Factors of Long-Term Survival after Neoadjuvant Radiotherapy and Chemotherapy in High-Risk Breast Cancer
    Haussmann, Jan
    Budach, Wilfried
    Nestle-Kraemling, Carolin
    Wollandt, Sylvia
    Tamaskovics, Balint
    Corradini, Stefanie
    Boelke, Edwin
    Krug, David
    Fehm, Tanja
    Ruckhaeberle, Eugen
    Audretsch, Werner
    Jazmati, Danny
    Matuschek, Christiane
    CANCERS, 2022, 14 (16)
  • [2] Radiotherapy and chemotherapy in high-risk breast cancer
    Raffle, AE
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (05): : 331 - 331
  • [3] Predictive biomarkers of survival after neoadjuvant chemotherapy for breast cancer
    Galvez-Nino, Marco
    Roque, Katia
    Angel Bernabe, Luis
    Castillo, Miluska
    Sanchez, Joselyn
    Landa Baella, Maria
    Calderon, Gabriela
    De la Cruz, Miguel
    Dunstan, Jorge
    Abugatas, Julio
    Cotrina, Jose
    Castaneda, Carlos
    Gomez, Henry
    CANCER RESEARCH, 2020, 80 (04)
  • [4] Factors influencing pathological complete response and tumor regression in neoadjuvant radiotherapy and chemotherapy for high-risk breast cancer
    Haussmann, Jan
    Budach, Wilfried
    Nestle-Kraemling, Carolin
    Wollandt, Sylvia
    Jazmati, Danny
    Tamaskovics, Balint
    Corradini, Stefanie
    Boelke, Edwin
    Haussmann, Alexander
    Audretsch, Werner
    Matuschek, Christiane
    RADIATION ONCOLOGY, 2024, 19 (01)
  • [5] A pilot study of adjuvant bevacizumab and chemotherapy after neoadjuvant chemotherapy for high-risk breast cancer
    Mayer, E. L.
    Miller, K. D.
    Rugo, H. S.
    Peppercorn, J. M.
    Carey, L. A.
    Ryabin, N.
    Josephs, K.
    Winer, E. P.
    Burstein, H. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [6] Neoadjuvant radiotherapy for locally advanced and high-risk breast cancer
    Chidley, Phoebe
    Foroudi, Farshad
    Tacey, Mark
    Khor, Richard
    Yeh, Janice
    Bevington, Elaine
    Hyett, Anthony
    Loh, Su Wen
    Chew, Grace
    McCracken, James
    Neoh, Derek
    Yeo, Belinda
    Baker, Caroline
    Jassal, Sunil
    Law, Michael
    Zantuck, Natalie
    Cokelek, Margaret
    Guerrieri, Mario
    Brown, Belinda
    Stoney, David
    Ng, Michael
    Chao, Michael
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2021, 65 (03) : 345 - 353
  • [7] Predictive factors of conservative breast surgery after neoadjuvant chemotherapy for breast cancer
    Pilloy, J.
    Fleurier, C.
    Chas, M.
    Bedouet, L.
    Jourdan, M. L.
    Arbion, F.
    Body, G.
    Ouldamer, L.
    GYNECOLOGIE OBSTETRIQUE FERTILITE & SENOLOGIE, 2017, 45 (09): : 466 - 471
  • [8] Predictive factors before and after neoadjuvant chemotherapy for breast cancer.
    Pestalozzi, BC
    Caduff, R
    Rageth, C
    Fink, D
    Varga, Z
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 76S - 76S
  • [9] A pilot study of adjuvant bevacizumab after neoadjuvant chemotherapy for high-risk breast cancer
    Mayer, E. L.
    Miller, K. D.
    Rugo, H. S.
    Peppercorn, J. M.
    Carey, L. A.
    Ryabin, N.
    Winer, E. P.
    Burstein, H. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] Predictive factors associated with invasive lobular breast cancer after neoadjuvant chemotherapy
    Julian, T. B.
    Anderson, S.
    Fourchotte, V.
    Zieger, S.
    Mamounas, E.
    Bear, H.
    Costantino, J.
    Wolmark, N.
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (02) : 17 - 17
12345